Skip to main content
. 2019 Mar 15;10(3):3552–3559. doi: 10.19102/icrm.2019.100304

Table 1:

Pharmacokinetics of Antiarrhythmic Drugs

Antiarrhythmic Class Agent CYP Substrate P-gp Substrate Enzymes/Transporters Inhibited
Class Ia Quinidine 3A4 Yes 3A4, 2D6, P-gp
Procainamide No No None known
Disopyramide 3A4 No None known
Class Ib Lidocaine 1A2, 2B6, 2D6 No 1A2
Mexiletine 2D6, 1A2 No 1A2
Class Ic Flecainide 2D6 No 2D6
Propafenone 1A2, 2D6, 3A4 No 2D6
Class II Propranolol 2D6, 1A2, 2C19 Yes P-gp, weakly 2D6
Bisoprolol 3A4 (minor: 2D6) Possibly None known
Metoprolol 2D6 No None known
Carvedilol 2D6, 2C9 (minor: 3A4, 1A1, 1A2, 2C19, 2E1) No P-gp
Class III Amiodarone 3A4, 2C8 No 1A2, 2D6, 2C9, 3A4, P-gp
Dronedarone 3A4 No 3A4, 2D6, P-gp
Sotalol No No None known
Ibutilide No No None known
Dofetilide Insignificant No None known
Class IV Verapamil 3A4, 3A5, 2C8 (minor: 1A2, 2C9, 2C19, 2D6, 2E1) Yes 3A4, P-gp
Diltiazem 3A4, 2C8, 2C9, 2C19 Yes 3A4, possibly 2D6, P-gp

CYP: cytochrome P-450; P-gp: P-glycoprotein.